Background The lack of dystrophin expression in Duchenne muscular dystrophy (DMD)
induces muscle fibre and replacement by fibro‐adipose tissue. Although the role of some …

Background Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, leads
to progressive and fatal muscle weakness through yet‐to‐be‐fully deciphered molecular …

Duchenne muscular dystrophy (DMD) is characterized by increased muscle damage and an
abnormal blood flow after muscle contraction leading to a state of functional ischemia …

Fibrosis is a characteristic of Duchenne muscular dystrophy (DMD), yet the cellular and
molecular mechanisms responsible for DMD fibrosis are poorly understood. Utilizing the …

Potentially viable therapeutic approaches for Duchenne muscular dystrophy (DMD) are now
within reach. Indeed, clinical trials are currently under way. Two crucial aspects still need to …

Duchenne muscular dystrophy (DMD) is an hereditary disease characterized by loss of
muscle fibers and their progressive substitution by fat and fibrous tissue. Mesenchymal fibro …

Duchenne muscular dystrophy (DMD) is the most common genetic muscle disease affecting
1 in 3,500 live male births. It is an X-linked recessive disease caused by a defective …

Duchenne muscular dystrophy (DMD) causes severe disability and death of young men
because of progressive muscle degeneration aggravated by sterile inflammation. DMD is …

Fibrosis is the aberrant deposition of extracellular matrix (ECM) components during tissue
healing leading to loss of its architecture and function. Fibrotic diseases are often associated …

Duchenne muscular dystrophy (DMD) is an X-linked genetic disease in which the dystrophin
gene is mutated, resulting in dysfunctional dystrophin protein. Without dystrophin, the …